Shanghai Sanyou Medical Co. Ltd. (688085) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai Sanyou Medical Co. Ltd.

Why is Shanghai Sanyou Medical Co. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 7.13% and Operating profit at -19.34% over the last 5 years

The company has declared positive results in Mar'2025 after 9 consecutive negative quarters

RAW MATERIAL COST(Y) Fallen by -18.74% (YoY)
DEBTORS TURNOVER RATIO(HY) Highest at 6.07 times
NET SALES(Q) Highest at CNY 141.71 MM

With ROE of 1.92%, it has a very expensive valuation with a 3.22 Price to Book Value

Over the past year, while the stock has generated a return of 37.98%, its profits have risen by 33.4% ; the PEG ratio of the company is 5

Market Beating Performance

The stock has generated a return of 37.98% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Sanyou Medical Co. Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shanghai Sanyou Medical Co. Ltd.

-8.47%

0.23

49.60%

China Shanghai Composite

23.91%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.68%

EBIT Growth (5y)

-27.58%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.19

Sales to Capital Employed (avg)

0.23

Tax Ratio

26.42%

Dividend Payout Ratio

9.03%

Pledged Shares

Institutional Holding

ROCE (avg)

11.81%

ROE (avg)

6.42%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

135

Industry P/E

Price to Book Value

2.05

EV to EBIT

162.71

EV to EBITDA

56.45

EV to Capital Employed

2.37

EV to Sales

7.01

PEG Ratio

13.18

Dividend Yield

0.02%

ROCE (Latest)

1.46%

ROE (Latest)

1.52%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET PROFIT(9M)

At CNY 29.11 MM has Grown at 51.66%

RAW MATERIAL COST(Y)

Fallen by -7.65% (YoY

-23What is not working for the Company

PRE-TAX PROFIT(Q)

At CNY 0.43 MM has Fallen at -97.15%

NET PROFIT(Q)

At CNY 3.85 MM has Fallen at -75.14%

INTEREST COVERAGE RATIO(Q)

Lowest at 34.39

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.59 times

NET SALES(Q)

At CNY 123.57 MM has Fallen at -8.94%

INTEREST(Q)

Highest at CNY 3.41 MM

OPERATING PROFIT(Q)

Lowest at CNY 1.17 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 0.95 %

Here's what is working for Shanghai Sanyou Medical Co. Ltd.

Raw Material Cost

Fallen by -7.65% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai Sanyou Medical Co. Ltd.

Pre-Tax Profit

At CNY 0.43 MM has Fallen at -97.15%

over average net sales of the previous four periods of CNY 15.04 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 3.85 MM has Fallen at -75.14%

over average net sales of the previous four periods of CNY 15.5 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 3.41 MM has Grown at 1,251.73%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 34.39

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Sales

At CNY 123.57 MM has Fallen at -8.94%

over average net sales of the previous four periods of CNY 135.7 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Interest

Highest at CNY 3.41 MM

in the last five periods and Increased by 1,251.73% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit

Lowest at CNY 1.17 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 0.95 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio

Lowest at 0.59 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Non Operating Income

Highest at CNY 0.59 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income